Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers

Author： Chotiyaputta Watcharasak

Publisher： Springer Publishing Company

ISSN： 1936-0533

Source： Hepatology International, Vol.4, Iss.4, 2010-12, pp. : 707-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus

By Drosten C. Nippraschk T. Manegold C. Meisel H. Brixner V. Roth W.K. Apedjinou A. Gunther S.

Journal of Clinical Virology, Vol. 29, Iss. 1, 2004-01 ,pp. : 59-68

Elsevier

Access to resources Recommend Favorite

Current use of hepatitis B immune globulin for prevention of de novo hepatitis B in recipients receiving anti-HBc-positive livers

By Pan Jen-Jung

Hepatology International, Vol. 5, Iss. 2, 2011-06 ,pp. : 635-643

Springer Publishing Company

Access to resources Recommend Favorite

Prevention of HBV reactivation from anti-HBc-positive liver grafts: searching for the consensus

By Roque Afonso A.M.

Journal of Hepatology, Vol. 40, Iss. 1, 2004-01 ,pp. : 186-188

Elsevier

Access to resources Recommend Favorite

Prophylaxis with anti-HBs immune globulins and nucleoside analogues after liver transplantation for HBV infection

By Villamil F.G.

Journal of Hepatology, Vol. 39, Iss. 4, 2003-10 ,pp. : 466-474

Elsevier

Access to resources Recommend Favorite

Long-term anti-TNFα therapy for ankylosing spondylitis in two patients with chronic HBV infection

By Sakellariou Grigorios Chatzigiannis Ioannis

Clinical Rheumatology, Vol. 26, Iss. 6, 2007-06 ,pp. : 950-952

Springer Publishing Company

Access to resources Recommend Favorite